[go: up one dir, main page]

GB927896A - Therapeutically active n-carboxyalkyl-2-phenylethylamine derivatives - Google Patents

Therapeutically active n-carboxyalkyl-2-phenylethylamine derivatives

Info

Publication number
GB927896A
GB927896A GB2464959A GB2464959A GB927896A GB 927896 A GB927896 A GB 927896A GB 2464959 A GB2464959 A GB 2464959A GB 2464959 A GB2464959 A GB 2464959A GB 927896 A GB927896 A GB 927896A
Authority
GB
United Kingdom
Prior art keywords
compound
formula
hydrogen atom
amino group
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2464959A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of GB927896A publication Critical patent/GB927896A/en
Expired legal-status Critical Current

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
    • H01L21/48Manufacture or treatment of parts, e.g. containers, prior to assembly of the devices, using processes not provided for in a single one of the groups H01L21/18 - H01L21/326 or H10D48/04 - H10D48/07

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Computer Hardware Design (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Power Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention comprises a compound of the general formula I <FORM:0927896/IV(a)/1> or an acid addition salt thereof, in which R1 represents a straight or branched chain alkylene group containing 1 to 6 carbon atoms, and R2 represents an alkyl group containing 1 to 5 carbon atoms, and the preparation thereof by (a) reacting a compound of formula II <FORM:0927896/IV(a)/2> or the nuclear mono- or di-benzyloxy derivative thereof with a compound of formula III <FORM:0927896/IV(a)/3> in which one of the symbols X and Y represents a halogen atom and the other an amino group, R represents a keto-oxygen when X represents a halogen atom, or represents a hydrogen atom and a hydroxyl group when X represents an amino group, and, if necessary, reducing the compound formed; or (b) reacting a compound of formula XII <FORM:0927896/IV(a)/4> or the nuclear mono- or di-benzyloxy derivative thereof with a compound of formula XIII <FORM:0927896/IV(a)/5> in which one of the symbols X1 and Y1 represents the oxygen atom of a carbonyl group and the other represents an amino group and a hydrogen atom, R11 represents a residue consisting of R1 as hereinbefore defined less a hydrogen atom, and reducing the Schiff's base so formed; or (c) carrying out the reaction (b) under reducing conditions without isolating the Schiff's base. Pharmaceutical compositions having bronchospasmolytic activity comprise the compounds of the invention mixed with or dissolved in pharmaceutically-acceptable fillers or solvents. Particularly in injection liquids, the acid addition salts are used, and in tablets, the free bases.
GB2464959A 1958-07-21 1959-07-17 Therapeutically active n-carboxyalkyl-2-phenylethylamine derivatives Expired GB927896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL229793 1958-07-21

Publications (1)

Publication Number Publication Date
GB927896A true GB927896A (en) 1963-06-06

Family

ID=19751291

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2464959A Expired GB927896A (en) 1958-07-21 1959-07-17 Therapeutically active n-carboxyalkyl-2-phenylethylamine derivatives

Country Status (1)

Country Link
GB (1) GB927896A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337207A (en) 1980-09-04 1982-06-29 Regents Of The University Of California Biologically active catecholamine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337207A (en) 1980-09-04 1982-06-29 Regents Of The University Of California Biologically active catecholamine derivatives

Similar Documents

Publication Publication Date Title
ES382751A1 (en) Thiophene derivatives
GB1024484A (en) Improvements in and relating to rubber compositions
GB927896A (en) Therapeutically active n-carboxyalkyl-2-phenylethylamine derivatives
GB1030025A (en) Dibenzocycloheptene derivatives
GB959993A (en) Camphor derivatives
GB959203A (en) Indole derivatives and salts thereof
GB945909A (en) Morphinone and codeinone derivatives
ES384946A1 (en) Novel adamantylurea derivatives and a process for the preparation thereof
GB914524A (en) Thiazole carboxylic acid-(5-nitrofuryl-2-methylidene)-hydrazides and process for their manufacture
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
ES301524A1 (en) Procedure for the preparation of antivirus compositions in a unit dosage form (Machine-translation by Google Translate, not legally binding)
GB823338A (en) Diquaternary salts of aminoalkyl piperidines
ES393554A1 (en) Thiazole derivatives and a process for the manufacture thereof
GB923942A (en) New compounds, processes for preparing them and pharmaceutical compositions containing them
GB1017450A (en) 2-amino-4-alkoxy-úË-triazines
GB982747A (en) Salts of 2-substituted (4-biphenylyl) acetic acids and therapeutic compositions thereof
GB1023203A (en) Propylamine derivatives
GB849755A (en) Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
GB1004927A (en) Improvements in or relating to amino-ketones, their preparation and compositions containing them
GB862251A (en) Urea and thiourea derivatives, processes for their production, and compositions containing them
GB890829A (en) Novel hydrazones and salts thereof and a process for the manufacture of same
GB950813A (en) Piperidine compounds
ES382438A1 (en) Pharmaceutical compositions
GB904680A (en) Process for the production of o-quinones
GB864146A (en) Aralkylaminoalkyl hydrazines